A formal regulatory inspection of Canterbury-based mental health services has set out a series of recommended changes for Health New Zealand and is continuing checks over the next 12 months.

Medsafe has opened a consultation on proposals to reduce barriers to accessing clozapine, a medicine used to treat treatment-resistant schizophrenia.

This report is the result of an inspection of Canterbury – Waitaha adult inpatient and associated mental health services. The Director of Mental Health has powers under section 99 of the Mental Health ...

Some parts of this information release would not be appropriate to release and, if requested, would be withheld under the Official Information Act 1982 (the Act). Where this is the case, the relevant ...

In addition to the briefings published below, we also publish additional information alongside Cabinet material, including briefings to Ministers. These can be found at Information releases.Some parts ...

This framework contains information for health professionals and the public on the standards they should expect for evidence-based assessment, diagnosis, and treatment for ADHD in New Zealand.

The Ministry of Health has issued a public warning about the Suntree - Vanilla Cream (30ml) vaping product as it contains too much of a chemical associated with a lung injury called ‘popcorn lung’.

This privacy statement applies to the Ministry of Health Jobs website, which is owned and administered by the Ministry of Health New Zealand.